| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |